These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 16488468
1. Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients. Gudleviciene Z, Didziapetriene J, Ramael M, Uleckiene S, Valuckas KP. Gynecol Oncol; 2006 Sep; 102(3):530-3. PubMed ID: 16488468 [Abstract] [Full Text] [Related]
2. [Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer]. Li CY, Liu JH, Huang BJ. Ai Zheng; 2004 Nov; 23(11 Suppl):1396-9. PubMed ID: 15566643 [Abstract] [Full Text] [Related]
3. Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women. Lee SA, Kim JW, Roh JW, Choi JY, Lee KM, Yoo KY, Song YS, Kang D. Gynecol Oncol; 2004 Apr; 93(1):14-8. PubMed ID: 15047208 [Abstract] [Full Text] [Related]
4. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women. Bhattacharya P, Sengupta S. Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204 [Abstract] [Full Text] [Related]
5. Impact of polymorphism in IL-1RA gene on the risk of cervical cancer. Tamandani DM, Sobti RC, Shekari M, Kaur S, Huria A. Arch Gynecol Obstet; 2008 Jun; 277(6):527-33. PubMed ID: 18008080 [Abstract] [Full Text] [Related]
6. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Li T, Lu ZM, Guo M, Wu QJ, Chen KN, Xing HP, Mei Q, Ke Y. Cancer; 2002 Dec 15; 95(12):2571-6. PubMed ID: 12467072 [Abstract] [Full Text] [Related]
11. p53 at codon 72 polymorphism, human papillomavirus infection and cervical lesions: a cross-sectional study from northeastern Italy. Comar M, Molin GD, Guaschino S, Campello C. Eur J Obstet Gynecol Reprod Biol; 2004 Jun 15; 114(2):210-4. PubMed ID: 15140517 [Abstract] [Full Text] [Related]
12. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency. Govan VA, Loubser S, Saleh D, Hoffman M, Williamson AL. Int J Immunogenet; 2007 Jun 15; 34(3):213-7. PubMed ID: 17504512 [Abstract] [Full Text] [Related]
13. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer. Dokianakis DN, Spandidos DA. Mol Cell Biol Res Commun; 2000 Feb 15; 3(2):111-4. PubMed ID: 10775508 [Abstract] [Full Text] [Related]
19. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Minaguchi T, Kanamori Y, Matsushima M, Yoshikawa H, Taketani Y, Nakamura Y. Cancer Res; 1998 Oct 15; 58(20):4585-6. PubMed ID: 9788606 [Abstract] [Full Text] [Related]
20. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers. Szarka K, Veress G, Juhász A, Kónya J, Sápy T, Soós G, Hernádi Z, Gergely L. Anticancer Res; 2000 Oct 15; 20(3B):2161-7. PubMed ID: 10928171 [Abstract] [Full Text] [Related] Page: [Next] [New Search]